ArticleCancer research2020

A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer.

Tamas A Gonda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.